2/20/2019 7:10:23 AM
Medtronic Reports U.S. Commercial Launch Of Deep Brain Stimulation For Medically-Refractory Epilepsy
2/19/2019 6:53:38 AM
Medtronic Q3 GAAP EPS $0.94; Non-GAAP EPS $1.29
1/3/2019 4:33:26 PM
Calyxt Appoints William Koschak As CFO
11/20/2018 6:52:55 AM
Medtronic Q2 EPS $0.82; Non-GAAP EPS $1.22
11/19/2018 6:31:40 PM
Mazor Robotics Shareholders Approve Merger Agreement With Medtronic
11/14/2018 7:36:18 AM
Motus GI Q3 Net Loss $5.2 Mln Or $0.33/Shr
9/25/2018 7:01:32 AM
Motus GI Names Timothy Moran To Assume Role Of CEO And Member Of Board
9/20/2018 8:36:26 PM
Medtronic To Acquire Mazor Robotics For $58.50/ADS, Total Of $1.64 Bln
8/21/2018 7:16:40 AM
Medtronic Posts Q1 GAAP EPS Of $0.79; Non-GAAP EPS Of $1.17
8/14/2018 8:07:27 AM
Motus GI Q2 Net Loss $4.2 Mln Or $0.27 Per Share
7/31/2018 6:02:16 AM
United Therapeutics Reports FDA Approval Of NDA For Use Of Remodulin Injection In Implantable System For Remodulin